David Alan Campbell

Business address
C/O Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla, CA, 92037
Top holdings (ownership)
JANX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
David Alan Campbell has filed 18 SEC EDGAR filings since 10 Jun 2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 08 Jan 2025 07 Jan 2025 001-40475
144 Open Document Open Filing 07 Jan 2025
4 Open Document Open Filing 03 Jan 2025 02 Jan 2025 001-40475
4 Open Document Open Filing 27 Dec 2024 24 Dec 2024 001-40475
144 Open Document Open Filing 26 Dec 2024
4 Open Document Open Filing 03 Dec 2024 03 Dec 2024 001-40475
4 Open Document Open Filing 27 Nov 2024 25 Nov 2024 001-40475
SC 13G/A Open Document Open Filing SC 13G/A 14 Nov 2024
4 Open Document Open Filing 30 Oct 2024 28 Oct 2024 001-40475
4 Open Document Open Filing 27 Sep 2024 27 Sep 2024 001-40475
144 Open Document Open Filing 27 Sep 2024
SC 13G/A Open Document Open Filing SC 13G/A 09 Feb 2024
4 Open Document Open Filing FORM 4 SUBMISSION 03 Jan 2024 02 Jan 2024 001-40475
SC 13G/A Open Document Open Filing SC 13G/A 10 Feb 2023
4 Open Document Open Filing FORM 4 SUBMISSION 05 Jan 2023 03 Jan 2023 001-40475
SC 13G Open Document Open Filing SC 13G 11 Feb 2022
4 Open Document Open Filing FORM 4 SUBMISSION 05 Jan 2022 03 Jan 2022 001-40475
3 Open Document Open Filing FORM 3 SUBMISSION 10 Jun 2021 10 Jun 2021 001-40475